Page last updated: 2024-11-12

ampullosporin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ampullosporin: a 15-membered peptaibol-type antibiotic from Sepedonium ampullosporum; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16133504
MeSH IDM0283009

Synonyms (2)

Synonym
SMP2_000030
ampullosporin

Research Excerpts

Overview

Ampullosporin A is a 15-mer peptaibol type polypeptide that induces pigment formation by the fungus Phoma destructiva. It forms voltage-dependent ion channels in membranes and exhibits hypothermic effects in mice.

ExcerptReferenceRelevance
"Ampullosporin A is a medium-length (14-amino acid long) hydrophobic peptide of the peptaibol family. "( An EPR study of ampullosporin A, a medium-length peptaibiotic, in bicelles and vesicles.
Bortolus, M; Dalzini, A; Formaggio, F; Gobbo, M; Maniero, AL; Toniolo, C, 2016
)
2.22
"Ampullosporin A is a 15-mer peptaibol type polypeptide that induces pigment formation by the fungus Phoma destructiva, forms voltage-dependent ion channels in membranes and exhibits hypothermic effects in mice. "( Crystal structure and conformational analysis of ampullosporin A.
Bohl, M; Görls, H; Gräfe, U; Kronen, M; Nguyen, HH; Reissmann, S; Sühnel, J,
)
1.83

Actions

ExcerptReferenceRelevance
"Ampullosporin displays narrow-spectrum antibacterial and antifungal activity, induces pigment formation by Phoma destructiva, causes hypothermia and decreased spontaneous locomotor activity in mice in dosages > 1 mg/kg."( Ampullosporin, a new peptaibol-type antibiotic from Sepedonium ampullosporum HKI-0053 with neuroleptic activity in mice.
Berg, A; Dornberger, K; Fleck, W; Gräfe, U; Härtl, A; Heinze, S; Ritzau, M; Schlegel, B, 1997
)
2.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's8 (66.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.38 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.22 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]